Progress in xenotransplantation: overcoming immune barriers
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
A major limitation of organ allotransplantation is the insufficient supply of donor organs. Consequently, thousands of patients die every year while waiting for a transplant. Progress in xenotransplantation that has permitted pig organ graft survivals of years in non-human primates has led to renewed excitement about the potential of this approach to alleviate the organ shortage. In 2022, the first pig-to-human heart transplant was performed on a compassionate use basis, and xenotransplantation experiments using pig kidneys in deceased human recipients provided encouraging data. Many advances in xenotransplantation have resulted from improvements in the ability to genetically modify pigs using CRISPR–Cas9 and other methodologies. Gene editing has the capacity to generate pig organs that more closely resemble those of humans and are hence more physiologically compatible and less prone to rejection. Despite such modifications, immune responses to xenografts remain powerful and multi-faceted, involving innate immune components that do not attack allografts. Thus, the induction of innate and adaptive immune tolerance to prevent rejection while preserving the capacity of the immune system to protect the recipient and the graft from infection is desirable to enable clinical xenotransplantation. This Review summarizes the current state of knowledge regarding immunological barriers to xenotransplantation and discusses the major approaches that are being used to overcome these barriers, including immunosuppression, genetic engineering of pigs and tolerance induction. As the demand for human organs for transplantation far exceeds the supply, many patients die while waiting for a transplant; xenotransplantation provides a potential near-term solution to the organ shortage. Advances in genetic engineering, immunosuppression and tolerance approaches have contributed to improved pig organ survival in non-human primates (NHPs). Functioning pig islet and heart grafts have survived in NHPs for months and functioning pig kidney grafts have survived in NHPs for years. In 2022, a pig heart was transplanted into a patient with heart failure and functioned for 7 weeks and xenotransplantation experiments using pig kidneys in deceased human recipients provided encouraging data. Mixed haematopoietic chimerism and thymic transplantation approaches have been successfully used to tolerize human T cells, B cells and natural killer cells in human immune system mice, providing proof of their potential to induce immune tolerance. Advances in applying tolerance approaches in NHPs, including genetic engineering of source pigs, support their potential to provide a long-term solution to the powerful immune barriers to xenotransplantation. As the demand for human organs for transplantation far exceeds the supply, many patients die while waiting for a transplant; xenotransplantation provides a potential near-term solution to the organ shortage. Advances in genetic engineering, immunosuppression and tolerance approaches have contributed to improved pig organ survival in non-human primates (NHPs). Functioning pig islet and heart grafts have survived in NHPs for months and functioning pig kidney grafts have survived in NHPs for years. In 2022, a pig heart was transplanted into a patient with heart failure and functioned for 7 weeks and xenotransplantation experiments using pig kidneys in deceased human recipients provided encouraging data. Mixed haematopoietic chimerism and thymic transplantation approaches have been successfully used to tolerize human T cells, B cells and natural killer cells in human immune system mice, providing proof of their potential to induce immune tolerance. Advances in applying tolerance approaches in NHPs, including genetic engineering of source pigs, support their potential to provide a long-term solution to the powerful immune barriers to xenotransplantation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Improvement in outcomes of clinical islet transplantation: 1999–2010
Barton, F. B., Rickels, M. R., Alejandro, R., Hering, B. J., Wease, S., Naziruddin, B., Oberholzer, J., Odorico, J. S., Garfinkel, M. R., Levy, M., et al. (2012) · Diabetes Care · doi:10.2337/dc12-0063 · Cited by 725
Cited by
Molecular mechanisms in liver repair and regeneration: from physiology to therapeutics
Ma, X., Huang, T., Chen, X., Li, Q., Liao, M., Fu, L., Huang, J., Yuan, K., Wang, Z., & Zeng, Y. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02104-8 · Cited by 133
Grattoni, A., Korbutt, G., Tomei, A. A., García, A. J., Pepper, A. R., Stabler, C., Brehm, M., Papas, K., Citro, A., Shirwan, H., et al. (2025) · Nature Reviews Endocrinology · doi:10.1038/s41574-024-01029-0 · Cited by 92
Self-citationCapella-Monsonís, H., Crum, R. J., Hussey, G. S., & Badylak, S. F. (2024) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2024.115347 · Cited by 84
Cellular dynamics in pig-to-human kidney xenotransplantation
Pan, W., Zhang, W., Zheng, B., Camellato, B. R., Stern, J., Lin, Z., Khodadadi-Jamayran, A., Kim, J., Sommer, P., Khalil, K., et al. (2024) · Med · doi:10.1016/j.medj.2024.05.003 · Cited by 46
Pig models in retinal research and retinal disease
McCall, M. A. (2024) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041296 · Cited by 21
Metadata
- Authors
- Sykes, M., & Sachs, D. H.
- Venue
- Nature Reviews Nephrology
- Published
- 2022-10-05
- Volume
- 18
- Issue
- 12
- Pages
- 745-761
- ISSN
- 1745-8323 (ISSN-L)
- 1759-5061
- 1759-507X
- OpenAlex
- W4301603526
- Cited by
- 130
- References
- 1
- FWCI
- 7.58
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Progress in xenotransplantation: overcoming immune barriers. https://app.cochat.ai/papers/10.1038/s41581-022-00624-6
- The paper
- Sykes, M., & Sachs, D. H. (2022). Progress in xenotransplantation: overcoming immune barriers. Nature Reviews Nephrology. https://doi.org/10.1038/s41581-022-00624-6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.